Artificial intelligence and the future of life sciences.

Over the past few decades, the number of health and 'omics-related data' generated and stored has grown exponentially. Patient information can be collected in real time and explored using various artificial intelligence (AI) tools in clinical trials; mobile devices can also be used to improve aspects of both the diagnosis and treatment of diseases. In addition, AI can be used in the development of new drugs or for drug repurposing, in faster diagnosis and more efficient treatment for various diseases, as well as to identify data-driven hypotheses for scientists. In this review, we discuss how AI is starting to revolutionize the life sciences sector. Copyright © 2021 Elsevier Ltd. All rights reserved.

Citation

Michel L Leite, Lorena S de Loiola Costa, Victor A Cunha, Victor Kreniski, Mario de Oliveira Braga Filho, Nicolau B da Cunha, Fabricio F Costa. Artificial intelligence and the future of life sciences. Drug discovery today. 2021 Nov;26(11):2515-2526

Mesh Tags

PMID: 34245910

search → result